A regional court in the southern German city of Munich has to reopen a massive damages case brought by buyers of lorries from across Europe after the European Union fined major manufacturers including Daimler and Volvo/Renault for having colluded on pricing. The Munich Higher Regional Court overturned a judgement handed down three years ago on Thursday, ruling - contrary to the opinion of the lower court - that the lawsuit was admissible. Buyers of trucks had brought the lawsuit after the Europe
(Reuters) -EU antitrust regulators have started an investigation into whether Zoetis blocked the market launch of a rival pain medicine for dogs, the European Commission said on Tuesday, a move that could result in a hefty fine for the U.S. pet products maker. Antitrust regulators on both sides of the Atlantic have recently cracked down on Big Tech and Big Pharma acquiring start-ups or small rivals in order to shut them down in what is known as killer acquisitions. Zoetis' Librela is currently the first and only monoclonal antibody medicine approved in Europe to treat pain associated with osteoarthritis in dogs.
European Commission officials are leaning toward the reprieve for Apple as part of a five-month market investigation which concludes in February, according to people familiar with the matter who spoke on condition of anonymity.